Kenneth Cunningham serves as Executive at Verona Pharma plc, where they oversee executive responsibilities. Since joining the company, Kenneth Cunningham has executed 7 insider transactions totaling $166.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 7, 2025 involved selling 72,000 shares valued at $0.
Kenneth Cunningham currently holds 72,000 shares of Verona Pharma plc (VRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth Cunningham has been a net seller of VRNA stock. They have purchased $0 and sold $166.0K worth of shares.
Kenneth Cunningham's most recent insider trade was on Oct 7, 2025, when they sold 72,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 7, 2025 | VRNA | $0 | Disposition | 79,776 | $N/A | Discretionary |
| Aug 1, 2025 | VRNA | $0 | Option Exercise | 24,000 | $N/A | Discretionary |
| Aug 1, 2025 | VRNA | $142.0K | Sale | 10,808 | $13.14 | Discretionary |
| May 4, 2021 | VRNA | $11.0K | Sale | 13,112 | $0.84 | Discretionary |
| Feb 1, 2021 | VRNA | $13.0K | Sale | 13,104 | $0.99 | Discretionary |